The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Does a targeting ligand influence nanoparticle tumor localization or uptake?
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Maeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495
PEGylation, successful approach to drug delivery
Veronese, F. M., & Pasut, G. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03575-0 · Cited by 2,339
Exploiting the enhanced permeability and retention effect for tumor targeting
Iyer, A. K., Khaled, G., Fang, J., & Maeda, H. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.07.005 · Cited by 1,846
Formulation of functionalized PLGA-PEG Nanoparticles for in vivo targeted drug delivery
Cheng, J., Teply, B. A., Sherifi, I., Sung, J., Luther, G., Gu, F. X., Levy-Nissenbaum, E., Radovic-Moreno, A. F., Langer, R., & Farokhzad, O. C. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.09.047 · Cited by 1,273
Kirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K., Nielsen, U. B., Marks, J. D., Benz, C. C., & Park, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4199 · Cited by 1,125
Bartlett, D. W., Su, H., Hildebrandt, I. J., Weber, W. A., & Davis, M. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707461104 · Cited by 803
Daniels, T. R., Delgado, T., Rodriguez, J. A., Helguera, G., & Penichet, M. L. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.06.010 · Cited by 634
Folate Receptor-Mediated Drug Targeting: From Therapeutics to Diagnostics
Hilgenbrink, A. R., & Low, P. S. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20457 · Cited by 625
Maeda, H., Fang, J., Inutsuka, T., & Kitamoto, Y. (2003) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00271-0 · Cited by 537
Fang, C., Shi, B., Pei, Y.-Y., Hong, M.-H., Wu, J., & Chen, H.-Z. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.08.002 · Cited by 424
Gene therapy progress and prospects: non-viral gene therapy by systemic delivery
Li, S.-D., & Huang, L. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302838 · Cited by 391
Kircheis, R., Wightman, L., Schreiber, A., Robitza, B., Rössler, V, Kursa, M., & Wagner, E. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301351 · Cited by 350
Pharmacokinetic Consequences of Pegylation
Hamidi, M., Azadi, A., & Rafiei, P. (2006) · Drug Delivery · doi:10.1080/10717540600814402 · Cited by 301
Pros and Cons of the Liposome Platform in Cancer Drug Targeting
Gabizon, A. A., Shmeeda, H., & Zalipsky, S. (2006) · Journal of Liposome Research · doi:10.1080/08982100600848769 · Cited by 272
Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes.
Xu, L., Huang, C., Huang, W., Tang, W., Rait, A. S., Yin, Y. Z., Cruz, I., Xiang, L., Pirollo, K. F., & Chang, E. H. (2002) · PubMed · Cited by 243
Self-citationHydrophobization and bioconjugation for enhanced siRNA delivery and targeting
De Paula, D., Bentley, M. V. L. B., & Mahato, R. I. (2007) · RNA · doi:10.1261/rna.459807 · Cited by 228
Sundaresan, G., Yazaki, P. J., Shively, J. E., Finn, R. D., Larson, S. M., Raubitschek, A. A., Williams, L. E., Chatziioannou, A. F., Gambhir, S. S., & Wu, A. M. (2003) · PubMed · Cited by 222
Xu, L., Pirollo, K. F., Tang, W.-H., Rait, A., & Chang, E. H. (1999) · Human Gene Therapy · doi:10.1089/10430349950016357 · Cited by 218
Self-citationWu, A. M., Yazaki, P. J., Tsai, S.-W., Nguyen, K., Anderson, A.-L., McCarthy, D. W., Welch, M. J., Shively, J. E., Williams, L. E., Raubitschek, A. A., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150228297 · Cited by 214
Pun, S. H., Tack, F., Bellocq, N. C., Cheng, J., Grubbs, B. H., Jensen, G. S., Davis, M. E., Brewster, M., Janicot, M., Janssens, B., et al. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.7.918 · Cited by 201
Materializing the Potential of Small Interfering RNA via a Tumor-Targeting Nanodelivery System
Pirollo, K. F., Rait, A., Zhou, Q., Hwang, S. H., Dagata, J. A., Zon, G., Hogrefe, R. I., Palchik, G., & Chang, E. H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4535 · Cited by 195
Self-citationGaranger, E., Boturyn, D., & Dumy, P. (2007) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152007781668706 · Cited by 185
Cellular Dynamics of EGF Receptor–Targeted Synthetic Viruses
de Bruin, K., Ruthardt, N., von Gersdorff, K., Bausinger, R., Wagner, E., Ogris, M., & Bräuchle, C. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300176 · Cited by 168
Systemic p53 Gene Therapy of Cancer with Immunolipoplexes Targeted by Anti-Transferrin Receptor scFv
Xu, L., Tang, W., Huang, C., Alexander, W., Xiang, L., Pirollo, K. F., Rait, A. S., & Chang, E. H. (2001) · Molecular Medicine · doi:10.1007/bf03401962 · Cited by 150
Self-citationTumor-Targeting Nanoimmunoliposome Complex for Short Interfering RNA Delivery
Pirollo, K. F., Zon, G., Rait, A. S., Zhou, Q., Yu, W. H., Hogrefe, R. I., & Chang, E. H. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.117 · Cited by 147
Self-citationPharmacokinetics and Pharmacodynamics of Lipidic Nano-Particles in Cancer
Allen, T. M., Cheng, W., Hare, J. I., & Laginha, K. M. (2006) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152006778699121 · Cited by 143
Khalid, M. N., Simard, P., Hoarau, D., Dragomir, A., & Leroux, J. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9662-5 · Cited by 141
Monitoring cancer treatment with PET/CT: does it make a difference?
Weber, W., & Figlin, R. A. (2007) · PubMed · Cited by 125
In Vivo Imaging of64Cu-Labeled Polymer Nanoparticles Targeted to the Lung Endothelium
Rossin, R., Muro, S., Welch, M. J., Muzykantov, V. R., & Schuster, D. P. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.045302 · Cited by 124
Selective gene delivery for cancer therapy using cationic liposomes: In vivo proof of applicability
Dass, C. R., & Choong, P. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.04.009 · Cited by 114
Hussain, S., Plückthun, A., Allen, T. M., & Zangemeister‐Wittke, U. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0615 · Cited by 99
A sterically stabilized immunolipoplex for systemic administration of a therapeutic gene
Yu, W. H., Pirollo, K. F., Rait, A. S., Yu, B., Xiang, L., Huang, W.-Q., Zhou, Q., Ertem, G., & Chang, E. H. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302304 · Cited by 86
Self-citationYu, W. H. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh049 · Cited by 85
Exploiting EPR in Polymer Drug Conjugate Delivery for Tumor Targeting
Modi, S., Jain, J. P., Domb, A. J., & Kumar, N. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206779026272 · Cited by 69
Meyer, M., & Wagner, E. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.1062 · Cited by 68
Vector Targeting for Therapeutic Gene Delivery
Curiel, D. T., & Douglas, J. T. (2002) · doi:10.1002/0471234303 · Cited by 31
Immunoliposomes: A Targeted Delivery Tool for Cancer Treatment
Pirollo, K. F., Xu, L., & Chang, E. H. (2002) · doi:10.1002/0471234303.ch3 · Cited by 11
Self-citation
Cited by
Impact of Nanotechnology on Drug Delivery
Farokhzad, O. C., & Langer, R. (2009) · ACS Nano · doi:10.1021/nn900002m · Cited by 3,348
Delivering nanomedicine to solid tumors
Jain, R. K., & Stylianopoulos, T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.139 · Cited by 3,180
Bertrand, N., Wu, J., Xu, X., Kamaly, N., & Farokhzad, O. C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.009 · Cited by 2,824
Danhier, F., Feron, O., & Préat, V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,800
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164
Metadata
- Authors
- Pirollo, K. F., & Chang, E. H.
- Venue
- Trends in Biotechnology
- Publisher
- Elsevier BV
- Published
- 2008-10
- Volume
- 26
- Issue
- 10
- Pages
- 552-558
- ISSN
- 0167-7799 (ISSN-L)
- OpenAlex
- W1995340305
- Cited by
- 347
- References
- 39
- FWCI
- 0.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.